Completed PHASE2 INTERVENTIONAL 2-arm NCT01863251

Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia

Sponsor: Yale University

Conditions Opiate Dependence Stimulant Dependence

Interventions Atomoxetine

Updated 6 times since 2017 Last updated: Apr 25, 2017 Started: May 31, 2013 Primary completion: Aug 31, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01863251, this PHASE2 trial focuses on Opiate Dependence and Stimulant Dependence and remains completed. Sponsored by Yale University, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
May 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — May 2017 [monthly]

Completed PHASE2

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kota Bharu, Malaysia